[Potassium citrate versus potassium chloride in essential hypertension. Effects on hemodynamic, hormonal and metabolic parameters].
A study was conducted on 25 patients (18 men, seven women; mean age 48 [24-70] years) with essential hypertension (EH) to see whether an increase in potassium supply influences blood pressure as well as metabolic and hormonal parameters, and whether the anion administered together with potassium affects the results. In a randomized, cross-over trial sequence the patients daily received 120 mmol potassium chloride, 120 mmol potassium citrate or a placebo, each for 8 weeks. Between each of the three periods there was a "wash-out" phase of 4 weeks each. After 8 weeks of potassium citrate intake the systolic and diastolic pressures were reduced significantly, by a mean of 6.2/3.8 mm Hg (P < 0.05). But after potassium chloride there was only a small, not significant, reduction. Metabolic and hormonal parameters (fasting glucose concentration, glucose tolerance test, lipid electrophoresis; plasma renin activity, plasma concentration of aldosterone, noradrenaline and insulin) were not significantly changed.--These findings suggest that an increased supply of potassium has a favourable haemodynamic effect, but this varies markedly between different potassium salts. An increase in potassium supply should thus be considered as an additional measure in the treatment of EH. As long as renal function is normal no unfavourable metabolic effect need be feared.
Overlack
A
A
Medizinische Universitäts-Poliklinik Bonn.
Maus
B
B
Ruppert
M
M
Lennarz
M
M
Kolloch
R
R
Stumpe
K O
KO
D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D002951:Citrates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D019343:Citric Acid; D018592:Cross-Over Studies; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D010919:Placebos; D011189:Potassium Chloride / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D012083:Renin / Q000097:blood; D013997:Time Factors
D001786:Blood Glucose; D002951:Citrates; D007328:Insulin; D008055:Lipids; D010919:Placebos; D019343:Citric Acid; D000450:Aldosterone; D011189:Potassium Chloride; D012083:Renin; D009638:Norepinephrine
Kaliumcitrat versus Kaliumchlorid bei essentieller Hypertonie. Wirkung auf hämodynamische, hormonelle und metabolische Parameter.